Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)
Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%
Dr Reddys Laboratories pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Dr Reddys Laboratories's pe ratio was 27.1× on Nov 11, 2026, against 18.5× a year earlier. Over the last 5 years it ranged from 16.7× to 46.9×, with a median of 21.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 27.1× | +8.5 |
| 2025 | Dec 31, 2025 | 18.6× | −1.6 |
| 2024 | Dec 31, 2024 | 20.2× | −1.1 |
| 2023 | Dec 29, 2023 | 21.4× | −8.8 |
| 2022 | Dec 30, 2022 | 30.2× | −16.7 |
| 2021 | Dec 31, 2021 | 46.9× | +2.6 |
| 2020 | Dec 31, 2020 | 44.3× | +18.7 |
| 2019 | Dec 31, 2019 | 25.6× | −18.9 |
| 2018 | Dec 31, 2018 | 44.5× | +11.2 |
| 2017 | Dec 29, 2017 | 33.3× | +7.0 |
| 2016 | Dec 30, 2016 | 26.3× | – |
See a number that looks wrong?